Emerging nanomaterials targeting macrophage adapted to abnormal metabolism in cancer and atherosclerosis therapy (Review)
- Authors:
- Miaomiao Xu
- Ying Cui
- Siyuan Wei
- Xuelong Cong
- Yiying Chen
- Shujie Tian
- Anqi Yao
- Weiwei Chen
- Lixing Weng
-
Affiliations: School of Geography and Biological Information, Nanjing University of Posts and Telecommunications, Nanjing, Jiangsu 210023, P.R. China, State Key Laboratory for Organic Electronics and Information Displays and Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, Nanjing, Jiangsu 210023, P.R. China, RDFZ Chaoyang Branch School, Beijing 100028, P.R. China - Published online on: December 6, 2023 https://doi.org/10.3892/ijmm.2023.5337
- Article Number: 13
-
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Yunna C, Mengru H, Lei W and Weidong C: Macrophage M1/M2 polarization. Eur J Pharmacol. 877:1730902020. View Article : Google Scholar : PubMed/NCBI | |
|
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 233:6425–6440. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Murray PJ and Wynn TAJ: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 11:723–737. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Mosser DM and Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Juhas U, Ryba-Stanisławowska M, Szargiej P and Myśliwska J: Different pathways of macrophage activation and polarization. Postepy Hig Med Dosw (Online). 69:496–502. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang T and He C: Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 44:38–50. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ploeger DT, Hosper NA, Schipper M, Koerts JA, de Rond S and Bank RA: Cell plasticity in wound healing: paracrine factors of M1/M2 polarized macrophages influence the phenotypical state of dermal fibroblasts. Cell Commun Signal. 11:292013. View Article : Google Scholar | |
|
Tu Z, Chen M, Wang M, Shao Z, Jiang X, Wang K, Yao Z, Yang S, Zhang X, Gao W, et al: Engineering bioactive M2 macrophage-polarized anti-inflammatory, antioxidant, and antibacterial scaffolds for rapid angiogenesis and diabetic wound repair. Adv Funct Mater. 31:21009242021. View Article : Google Scholar | |
|
Yin C, Zhao Q, Li W, Zhao Z, Wang J, Deng T, Zhang P, Shen K, Li Z and Zhang Y: Biomimetic anti-inflammatory nano-capsule serves as a cytokine blocker and M2 polarization inducer for bone tissue repair. Acta Biomater. 102:416–426. 2020. View Article : Google Scholar | |
|
Kim J: Regulation of immune cell functions by metabolic reprogramming. J Immunol Res. 2018:86054712018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang M, Chen F, Tang Y, Wang J, Chen X, Li X and Zhang X: Regulation of macrophage polarization and functional status by modulating hydroxyapatite ceramic micro/nano-topography. Mater Des. 213:1103022022. View Article : Google Scholar | |
|
O'Neill LAJ and Hardie DG: Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 493:346–355. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tu B, Gao Y, Sun F, Shi M and Huang Y: Lipid metabolism regulation based on nanotechnology for enhancement of tumor immunity. Front Pharmacol. 13:8404402022. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L, Chen H, Zhao R, Zhu M and Nie G: Nanomedicine targets iron metabolism for cancer therapy. Cancer Sci. 113:828–837. 2022. View Article : Google Scholar : | |
|
Lin X, Xiao Z, Chen T, Liang SH and Guo H: Glucose metabolism on tumor plasticity diagnosis, and treatment. Front Oncol. 10:3172020. View Article : Google Scholar | |
|
Prasad CP, Gogia A and Batra AJC: Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis. Clin Transl Oncol. 24:1844–1855. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang B and Shi J: Chemistry of advanced nanomedicines in cancer cell metabolism regulation. Adv Sci (Weinh). 7:20013882020. View Article : Google Scholar : PubMed/NCBI | |
|
Garedew A, Henderson SO and Moncada S: Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ. 17:1540–1550. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Galván-Peña S and O'Neill LAJ: Metabolic reprograming in macrophage polarization. Front Immunol. 5:4202014.PubMed/NCBI | |
|
Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, Liu R, Gao H, Tao B, Li W, et al: Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis. Mol Cell. 71:201–215.e7. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Bailey JD, Diotallevi M, Nicol T, McNeill E, Shaw A, Chuaiphichai S, Hale A, Starr A, Nandi M, Stylianou E, et al: Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation. Cell Rep. 28:218–230.e7. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Na YR, Je S and Seok SH: Metabolic features of macrophages in inflammatory diseases and cancer. Cancer Lett. 413:46–58. 2018. View Article : Google Scholar | |
|
Wang J, Yang P, Yu T, Gao M, Liu D, Zhang J, Lu C, Chen X, Zhang X and Liu Y: Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages. Int J Biol Sci. 18:6210–6225. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yang K, Xu J, Fan M, Tu F, Wang X, Ha T, Williams DL and Li C: Lactate suppresses macrophage pro-inflammatory response to LPS stimulation by inhibition of YAP and NF-κB activation via GPR81-mediated signaling. Front Immunol. 11:5879132020. View Article : Google Scholar | |
|
Wang F, Zhang S, Vuckovic I, Jeon R, Lerman A, Folmes CD, Dzeja PP and Herrmann J: Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab. 28:463–475.e4. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang T, Liu H, Lian G, Zhang SY, Wang X and Jiang C: HIF1α-induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediators Inflamm. 2017:90293272017. View Article : Google Scholar | |
|
Zhihua Y, Yulin T, Yibo W, Wei D, Yin C, Jiahao X, Runqiu J and Xuezhong X: Hypoxia decreases macrophage glycolysis and M1 percentage by targeting microRNA-30c and mTOR in human gastric cancer. Cancer Sci. 110:2368–2377. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Everts B, Amiel E, Huang SCC, Smith AM, Chang CH, Lam WY, Redmann V, Freitas TC, Blagih J, van der Windt GJ, et al: TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKε supports the anabolic demands of dendritic cell activation. Nat Immunol. 15:323–332. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG, Raffatellu M and Osborne TF: Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13:540–549. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gordon S: Phagocytosis: An immunobiologic process. Immunity. 44:463–475. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cader MZ, Boroviak K, Zhang Q, Assadi G, Kempster SL, Sewell GW, Saveljeva S, Ashcroft JW, Clare S, Mukhopadhyay S, et al: C13orf31 (FAMIN) is a central regulator of immunometabolic function. Nat Immunol. 17:1046–1056. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Nomura M, Liu J, Rovira II, Gonzalez-Hurtado E, Lee J, Wolfgang MJ and Finkel T: Fatty acid oxidation in macrophage polarization. Nat Immunol. 17:216–217. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Schönfeld P and Wojtczak L: Short- and medium-chain fatty acids in energy metabolism: The cellular perspective. J Lipid Res. 57:943–954. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Coniglio S, Shumskaya M and Vassiliou E: Unsaturated fatty acids and their immunomodulatory properties. Biology (Basel). 12:2792023.PubMed/NCBI | |
|
Deng Y, Li W, Zhang Y, Li J, He F, Dong K, Hong Z, Luo R and Pei X: α-Linolenic acid inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation in vivo. Foods. 12:6822023. View Article : Google Scholar | |
|
Laval T, Chaumont L and Demangel C: Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis. Immunol Rev. 301:84–97. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Suzuki M, Takaishi S, Nagasaki M, Onozawa Y, Iino I, Maeda H, Komai T and Oda T: Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem. 288:10684–10691. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wu X, Simonavicius N, Tian H and Ling L: Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem. 281:34457–34464. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hidalgo MA, Carretta MD and Burgos RA: Long chain fatty acids as modulators of immune cells function: Contribution of FFA1 and FFA4 receptors. Front Physiol. 12:6683302021. View Article : Google Scholar : PubMed/NCBI | |
|
Forsman H, Dahlgren C, Mårtensson J, Björkman L and Sundqvist M: Function and regulation of GPR84 in human neutrophils. Br J Pharmacol. Mar 4–2023.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI | |
|
Danielski LG, Giustina AD, Bonfante S, Barichello T and Petronilho F: The NLRP3 inflammasome and its role in sepsis development. Inflammation. 43:24–31. 2020. View Article : Google Scholar | |
|
Kuhajda FP: Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition. 16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Moon JS, Lee S, Park MA, Siempos II, Haslip M, Lee PJ, Yun M, Kim CK, Howrylak J, Ryter SW, et al: UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J Clin Invest. 125:665–680. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Namgaladze D and Brüne B: Fatty acid oxidation is dispensable for human macrophage IL-4-induced polarization. Biochim Biophys Acta. 1841:1329–1335. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu L, Zhao Q, Yang T, Ding W and Zhao Y: Cellular metabolism and macrophage functional polarization. Int Rev Immunol. 34:82–100. 2015. View Article : Google Scholar | |
|
Hohensinner PJ, Lenz M, Haider P, Mayer J, Richter M, Kaun C, Goederle L, Brekalo M, Salzmann M, Sharma S, et al: Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation. Biochem Pharmacol. 190:1146342021. View Article : Google Scholar : PubMed/NCBI | |
|
Sola-García A, Cáliz-Molina MÁ, Espadas I, Petr M, Panadero-Morón C, González-Morán D, Martín-Vázquez ME, Narbona-Pérez ÁJ, López-Noriega L, Martínez-Corrales G, et al: Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging. Commun Biol. 6:2502023. View Article : Google Scholar : PubMed/NCBI | |
|
Luo J, Yang H and Song BL: Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 21:225–245. 2020. View Article : Google Scholar | |
|
Guo H, Callaway JB and Ting JP: Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat Med. 21:677–687. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou QD, Chi X, Lee MS, Hsieh WY, Mkrtchyan JJ, Feng AC, He C, York AG, Bui VL, Kronenberger EB, et al: Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins. Nat Immunol. 21:746–755. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao J, Chen J, Li M, Chen M and Sun C: Multifaceted functions of CH25H and 25HC to modulate the lipid metabolism, immune responses, and broadly antiviral activities. Viruses. 12:7272020. View Article : Google Scholar : PubMed/NCBI | |
|
Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 5:375–386. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hsieh WY, Zhou QD, York AG, Williams KJ, Scumpia PO, Kronenberger EB, Hoi XP, Su B, Chi X, Bui VL, et al: Toll-like receptors induce signal-specific reprogramming of the macrophage lipidome. Cell Metab. 32:128–143.e5. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
York AG, Williams KJ, Argus JP, Zhou QD, Brar G, Vergnes L, Gray EE, Zhen A, Wu NC, Yamada DH, et al: Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling. Cell. 163:1716–1729. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kieler M, Hofmann M and Schabbauer G: More than just protein building blocks: How amino acids and related metabolic pathways fuel macrophage polarization. FEBS J. 288:3694–3714. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan P, Hu X and Zhou Q: The nanomaterial-induced bystander effects reprogrammed macrophage immune function and metabolic profile. Nanotoxicology. 14:1137–1155. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Puchalska P, Huang X, Martin SE, Han X, Patti GJ and Crawford PA: Isotope tracing untargeted metabolomics reveals macrophage polarization-state-specific metabolic coordination across intracellular compartments. Science. 9:298–313. 2018. | |
|
O'Neill LA, Kishton RJ and Rathmell J: A guide to immunometabolism for immunologists. Nat Rev Immunol. 16:553–565. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Qualls JE, Subramanian C, Rafi W, Smith AM, Balouzian L, DeFreitas AA, Shirey KA, Reutterer B, Kernbauer E, Stockinger S, et al: Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe. 12:313–323. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yue Y, Huang W, Liang J, Guo J, Ji J, Yao Y, Zheng M, Cai Z, Lu L and Wang J: IL4I1 is a novel regulator of M2 macrophage polarization that can inhibit T cell activation via L-tryptophan and arginine depletion and IL-10 production. PLoS One. 10:e01429792015. View Article : Google Scholar : PubMed/NCBI | |
|
Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, et al: An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 478:197–203. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Huang SCC, Smith AM, Everts B, Colonna M, Pearce EL, Schilling JD and Pearce EJ: Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity. 45:817–830. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, Wang J, Ben-Sahra I, Byles V, Polynne-Stapornkul T, et al: Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 5:e116122016. View Article : Google Scholar : PubMed/NCBI | |
|
Liu PS, Wang H, Li X, Chao T, Teav T, Christen S, Di Conza G, Cheng WC, Chou CH, Vavakova M, et al: α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol. 18:985–994. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou W, Hu G, He J, Wang T, Zuo Y, Cao Y, Zheng Q, Tu J, Ma J, Cai R, et al: SENP1-Sirt3 signaling promotes α-ketoglutarate production during M2 macrophage polarization. Cell Rep. 39:1106602022. View Article : Google Scholar | |
|
Palmieri EM, Menga A, Martín-Pérez R, Quinto A, Riera-Domingo C, De Tullio G, Hooper DC, Lamers WH, Ghesquière B, McVicar DW, et al: Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis. Cell Rep. 20:1654–1666. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Mazzone M, Menga A and Castegna A: Metabolism and TAM functions-it takes two to tango. FEBS J. 285:700–716. 2018. View Article : Google Scholar | |
|
Ryan DG and O'Neill LAJ: Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol. 38:289–313. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
McGettrick AF and O'Neill LAJ: How metabolism generates signals during innate immunity and inflammation. J Biol Chem. 288:22893–22898. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
O'Neill LAJ: A broken krebs cycle in macrophages. Immunity. 42:393–394. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jha AK, Huang SCC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, et al: Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 42:419–430. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Infantino V, Pierri CL and Iacobazzi V: Metabolic routes in inflammation: The citrate pathway and its potential as therapeutic target. Curr Med Chem. 26:7104–7116. 2019. View Article : Google Scholar | |
|
Infantino V, Iacobazzi V, Palmieri F and Menga A: ATP-citrate lyase is essential for macrophage inflammatory response. Biochem Biophys Res Commun. 440:105–111. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tannahill G, Curtis A, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al: Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 496:238–242. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H and Ling L: Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 429:188–193. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Toma I, Kang JJ, Sipos A, Vargas S, Bansal E, Hanner F, Meer E and Peti-Peterdi J: Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest. 118:2526–2534. 2008.PubMed/NCBI | |
|
Peti-Peterdi J, Kang JJ and Toma I: Activation of the renal renin-angiotensin system in diabetes-new concepts. Nephrol Dial Transplant. 23:3047–3049. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sadagopan N, Li W, Roberds SL, Major T, Preston GM, Yu Y and Tones MA: Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens. 20:1209–1215. 2007.PubMed/NCBI | |
|
Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, et al: Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 109:3260–3269. 2007. View Article : Google Scholar | |
|
Wu JY, Huang TW, Hsieh YT, Wang YF, Yen CC, Lee GL, Yeh CC, Peng YJ, Kuo YY, Wen HT, et al: Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol Cell. 77:213–227.e5. 2020. View Article : Google Scholar | |
|
Wunderer F, Traeger L, Sigurslid HH, Meybohm P, Bloch DB and Malhotra R: The role of hepcidin and iron homeostasis in atherosclerosis. Pharmacol Res. 153:1046642020. View Article : Google Scholar : PubMed/NCBI | |
|
Xia Y, Li Y, Wu X, Zhang Q, Chen S, Ma X and Yu M: Ironing out the details: How iron orchestrates macrophage polarization. Front Immunol. 12:6695662021. View Article : Google Scholar : PubMed/NCBI | |
|
Liang G, Sakamoto A, Cornelissen A, Hong CC and Finn AV: Ironing-out the role of hepcidin in atherosclerosis. Arterioscler Thromb Vasc Biol. 39:303–305. 2019. View Article : Google Scholar | |
|
Marques L, Negre-Salvayre A, Costa L and Canonne-Hergaux F: Iron gene expression profile in atherogenic Mox macrophages. Biochim Biophys Acta. 1862:1137–1146. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Handa P, Thomas S, Morgan-Stevenson V, Maliken BD, Gochanour E, Boukhar S, Yeh MM and Kowdley KV: Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis. J Leukoc Biol. 105:1015–1026. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Cai X, Ma R, Fu W, Zhang C and Du X: Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. J Cell Physiol. 234:18792–18800. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Que KT, Zhang Z, Yi ZJ, Zhao PX, You Y, Gong JP and Liu ZJ: Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl-p53 pathway. Cancer Med. 7:4012–4022. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CY and Babitt JL: Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 23:189–197. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kanamori Y, Murakami M, Matsui T and Funaba M: JNK facilitates IL-1β-induced hepcidin transcription via JunB activation. Cytokine. 111:295–302. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kanamori Y, Murakami M, Sugiyama M, Hashimoto O, Matsui T and Funaba M: Hepcidin and IL-1β. Vitam Horm. 110:143–156. 2019. View Article : Google Scholar | |
|
Zhang Z, Zhang F, An P, Guo X, Shen Y, Tao Y, Wu Q, Zhang Y, Yu Y, Ning B, et al: Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood. 118:1912–1922. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang L, Zheng H, Lyu Q, Hayashi S, Sato K, Sekido Y, Nakamura K, Tanaka H, Ishikawa K, Kajiyama H, et al: Lysosomal nitric oxide determines transition from autophagy to ferroptosis after exposure to plasma-activated Ringer's lactate. Redox Biol. 43:1019892021. View Article : Google Scholar : PubMed/NCBI | |
|
Krümmel B, Plötz T, Jörns A, Lenzen S and Mehmeti I: The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death. Biochim Biophys Acta Mol Basis Dis. 1867:1661142021. View Article : Google Scholar : PubMed/NCBI | |
|
de Goede KE, Driessen AJM and Van den Bossche J: Metabolic cancer-macrophage crosstalk in the tumor microenvironment. Biology (Basel). 9:3802020.PubMed/NCBI | |
|
Ling J, Chang Y, Yuan Z, Chen Q, He L and Chen T: Designing lactate dehydrogenase-mimicking SnSe nanosheets to reprogram tumor-associated macrophages for potentiation of photothermal immunotherapy. ACS Appl Mater Interfaces. 14:27651–27665. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong H, Kim S, Hong BJ, Lee CJ, Kim YE, Bok S, Oh JM, Gwak SH, Yoo MY, Lee MS, et al: Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis. Cancer Res. 79:795–806. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Y, Xu J and Lan H: Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications. J Hematol Oncol. 12:762019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu D, Chang C, Lu N, Wang X, Lu Q, Ren X, Ren P, Zhao D, Wang L, Zhu Y, et al: Comprehensive proteomics analysis reveals metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment. J Proteome Res. 16:288–297. 2017. View Article : Google Scholar | |
|
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, et al: Lactate metabolism in human lung tumors. Cell. 171:358–371.e9. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Goswami KK, Banerjee S, Bose A and Baral R: Lactic acid in alternative polarization and function of macrophages in tumor microenvironment. Hum Immunoll. 83:409–417. 2022. View Article : Google Scholar | |
|
Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, et al: Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 513:559–563. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chiu DKC, Xu IMJ, Lai RKH, Tse AP, Wei LL, Koh HY, Li LL, Lee D, Lo RC, Wong CM, et al: Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26. Hepatology. 64:797–813. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Lu J, Tang Y, Xie W, Zhang H, Wang B, Zhang S, Hou W, Zou C, Jiang P and Zhang W: PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages. Cancer Lett. 529:19–36. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, et al: Metabolic regulation of gene expression by histone lactylation. Nature. 574:575–580. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Locatelli SL, Careddu G, Serio S, Consonni FM, Maeda A, Viswanadha S, Vakkalanka S, Castagna L, Santoro A, Allavena P, et al: Targeting cancer cells and tumor microenvironment in preclinical and clinical models of hodgkin lymphoma using the dual PI3Kδ/γ inhibitor RP6530. Clin Cancer Res. 25:1098–1112. 2019. View Article : Google Scholar | |
|
Ohashi T, Aoki M, Tomita H, Akazawa T, Sato K, Kuze B, Mizuta K, Hara A, Nagaoka H, Inoue N and Ito Y: M2-like macrophage polarization in high lactic acid-producing head and neck cancer. Cancer Sci. 108:1128–1134. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar V: Targeting macrophage immunometabolism: Dawn in the darkness of sepsis. Int Immunopharmacol. 58:173–185. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kanmani P and Kim H: Protective effects of lactic acid bacteria against TLR4 induced inflammatory response in hepatoma HepG2 cells through modulation of toll-like receptor negative regulators of mitogen-activated protein kinase and NF-κB signaling. Front Immunol. 9:15372018. View Article : Google Scholar | |
|
Feng R, Morine Y, Ikemoto T, Imura S, Iwahashi S, Saito Y and Shimada M: Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction. Cell Commun Signal. 16:542018. View Article : Google Scholar : PubMed/NCBI | |
|
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al: Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 25:486–541. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Carmona-Fontaine C, Deforet M, Akkari L, Thompson CB, Joyce JA and Xavier JB: Metabolic origins of spatial organization in the tumor microenvironment. Proc Natl Acad Sci USA. 114:2934–2939. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li K, Lin C, He Y, Lu L, Xu K, Tao B, Xia Z, Zeng R, Mao Y, Luo Z and Cai K: Engineering of cascade-responsive nanoplatform to inhibit lactate efflux for enhanced tumor chemo-immunotherapy. ACS Nano. 14:14164–14180. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Choi H, Yeo M, Kang Y, Kim HJ, Park SG, Jang E, Park SH, Kim E and Kang S: Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth. J Nanobiotechnology. 21:52023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Wu C, Tong X and Chen S: A biomimetic metal-organic framework nanosystem modulates immunosuppressive tumor microenvironment metabolism to amplify immunotherapy. J Control Release. 353:727–737. 2023. View Article : Google Scholar | |
|
Zhao S, Li H, Liu R, Tao N, Deng L, Xu Q, Hou J, Sheng J, Zheng J, Wang L, et al: Nitrogen-centered lactate oxidase nanozyme for tumor lactate modulation and microenvironment remodeling. J Am Chem Soc. 145:10322–10332. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang X, Zhao M, Wu Z, Chen C, Zhang Y, Wang L, Guo Q, Wang Q, Liang S, Hu S, et al: Nano-ultrasonic contrast agent for chemoimmunotherapy of breast cancer by immune metabolism reprogramming and tumor autophagy. ACS Nano. 16:3417–3431. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wu H, Han Y, Rodriguez Sillke Y, Deng H, Siddiqui S, Treese C, Schmidt F, Friedrich M, Keye J, Wan J, et al: Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol Med. 11:e106982019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Zhang X, Zheng L, Zhao H, Yan G, Zhang Q, Zhou Y, Lei J, Zhang J, Wang J, et al: RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis. Cancer Immunol Res. 8:710–721. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Niu Z, Shi Q, Zhang W, Shu Y, Yang N, Chen B, Wang Q, Zhao X, Chen J, Cheng N, et al: Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs. Nat Commun. 8:7662017. View Article : Google Scholar | |
|
Di Conza G, Tsai CH, Gallart-Ayala H, Yu YR, Franco F, Zaffalon L, Xie X, Li X, Xiao Z, Raines LN, et al: Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity. Nat Immunol. 22:1403–1415. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bidault G, Virtue S, Petkevicius K, Jolin HE, Dugourd A, Guénantin AC, Leggat J, Mahler-Araujo B, Lam BYH, Ma MK, et al: SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation. Nat Metab. 3:1150–1162. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Q, Lin X and Wang G: Targeting SREBP-1-mediated lipogenesis as potential strategies for cancer. Front Oncol. 12:9523712022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang T, Guo Z, Huo X, Gong Y, Li C, Huang J, Wang Y, Feng H, Ma X, Jiang C, et al: Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor. EBioMedicine. 77:1038722022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M and Huang J: The expanded role of fatty acid metabolism in cancer: New aspects and targets. Precis Clin Med. 2:183–191. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xiang W, Shi R, Kang X, Zhang X, Chen P, Zhang L, Hou A, Wang R, Zhao Y, Zhao K, et al: Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nat Commun. 9:25742018. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang M, Li X, Zhang J, Lu Y, Shi Y, Zhu C, Liu Y, Qin B, Luo Z, Du Y, et al: Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under hypoxia to sensitize immunotherapy. ACS Nano. 15:14522–14534. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hou L, Gong X, Yang J, Zhang H, Yang W and Chen X: Hybrid-membrane-decorated prussian blue for effective cancer immunotherapy via tumor-associated macrophages polarization and hypoxia relief. Adv Mater. 34:22003892022. View Article : Google Scholar | |
|
Yang Z, Luo Y, Yu H, Liang K, Wang M, Wang Q, Yin B and Chen H: Reshaping the tumor immune microenvironment based on a light-activated nanoplatform for efficient cancer therapy. Adv Mater. 34:21089082022. View Article : Google Scholar | |
|
Costa da Silva M, Breckwoldt MO, Vinchi F, Correia MP, Stojanovic A, Thielmann CM, Meister M, Muley T, Warth A, Platten M, et al: Iron induces anti-tumor activity in tumor-associated macrophages. Front Immunol. 8:14792017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang F, Li F, Lu GH, Nie W, Zhang L, Lv Y, Bao W, Gao X, Wei W, Pu K and Xie HY: Engineering magnetosomes for ferroptosis/immunomodulation synergism in cancer. ACS Nano. 13:5662–5673. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gu Z, Liu T, Liu C, Yang Y, Tang J, Song H, Wang Y, Yang Y and Yu C: Ferroptosis-strengthened metabolic and inflammatory regulation of tumor-associated macrophages provokes potent tumoricidal activities. Nano Lett. 21:6471–6479. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Altman BJ, Stine ZE and Dang CV: From Krebs to clinic: Glutamine metabolism to cancer therapy. Nat Rev Cancer. 16:619–634. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Zhang S, Sun J, Wang T, Liu Q, Wu G, Qian Y, Yang W, Wang Y and Wang W: Cigarette smoke promotes oral leukoplakia via regulating glutamine metabolism and M2 polarization of macrophage. Int J Oral Sci. 13:252021. View Article : Google Scholar : PubMed/NCBI | |
|
Oh MH, Sun IH, Zhao L, Leone RD, Sun IM, Xu W, Collins SL, Tam AJ, Blosser RL, Patel CH, et al: Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Invest. 130:3865–3884. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Du B, Jiao Q, Bai Y, Yu M, Pang M, Zhao M, Ma H and Yao H: Glutamine metabolism-regulated nanoparticles to enhance chemoimmunotherapy by increasing antigen presentation efficiency. ACS Appl Mater Interfaces. 14:8753–8765. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Hoves S, Ooi CH, Wolter C, Sade H, Bissinger S, Schmittnaegel M, Ast O, Giusti AM, Wartha K, Runza V, et al: Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity. J Exp Med. 215:859–876. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kashyap AS, Schmittnaegel M, Rigamonti N, Pais-Ferreira D, Mueller P, Buchi M, Ooi CH, Kreuzaler M, Hirschmann P, Guichard A, et al: Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proc Natl Acad Sci USA. 117:541–551. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, et al: CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 331:1612–1616. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu PS, Chen YT, Li X, Hsueh PC, Tzeng SF, Chen H, Shi PZ, Xie X, Parik S, Planque M, et al: CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol. 24:452–462. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Mai Z, Zhong J, Zhang J, Chen G, Tang Y, Ma W, Li G, Feng Z, Li F, Liang XJ, et al: Carrier-free immunotherapeutic nano-booster with dual synergistic effects based on glutaminase inhibition combined with photodynamic therapy. ACS Nano. 17:1583–1596. 2023. View Article : Google Scholar | |
|
Tabas I and Bornfeldt KE: Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 126:1209–1227. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, Thomas MJ, Hiltbold EM, Fessler MB and Parks JS: Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res. 51:3196–3206. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, et al: CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 11:155–161. 2010. View Article : Google Scholar : | |
|
Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S and Witztum JL: Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 25:1213–1219. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, et al: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464:1357–1361. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chen J, Su Y, Pi S, Hu B and Mao L: The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis. Front Cardiovasc Med. 8:6823892021. View Article : Google Scholar : PubMed/NCBI | |
|
Tomas L, Edsfeldt A, Mollet IG, Perisic Matic L, Prehn C, Adamski J, Paulsson-Berne G, Hedin U, Nilsson J, Bengtsson E, et al: Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques. Eur Heart J. 39:2301–2310. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mügge A: The role of reactive oxygen species in atherosclerosis. Z Kardiol. 87:851–864. 1998. | |
|
Kattoor AJ, Pothineni NVK, Palagiri D and Mehta J: Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 19:422017. View Article : Google Scholar : PubMed/NCBI | |
|
He J, Zhang W, Zhou X, Xu F, Zou J, Zhang Q, Zhao Y, He H, Yang H and Liu J: Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery. Bioact Mater. 19:115–126. 2022.PubMed/NCBI | |
|
Wang Y, Li L, Zhao W, Dou Y, An H, Tao H, Xu X, Jia Y, Lu S, Zhang J and Hu H: Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano. 12:8943–8960. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hu R, Dai C, Dong C, Ding L, Huang H, Chen Y and Zhang B: Living macrophage-delivered tetrapod PdH nanoenzyme for targeted atherosclerosis management by ROS scavenging, hydrogen anti-inflammation, and autophagy activation. ACS Nano. 16:15959–15976. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun W, Xu Y, Yao Y, Yue J, Wu Z, Li H, Shen G, Liao Y, Wang H and Zhou W: Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy. J Nanobiotechnology. 20:882022. View Article : Google Scholar | |
|
Han XB, Li HX, Jiang YQ, Wang H, Li XS, Kou JY, Zheng YH, Liu ZN, Li H, Li J, et al: Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation. Cell Death Dis. 8:e28642017. View Article : Google Scholar : PubMed/NCBI | |
|
Dai T, He W, Tu S, Han J, Yuan B, Yao C, Ren W and Wu A: Black TiO2 nanoprobe-mediated mild phototherapy reduces intracellular lipid levels in atherosclerotic foam cells via cholesterol regulation pathways instead of apoptosis. Bioact Mater. 17:18–28. 2022.PubMed/NCBI | |
|
Zhang Y, Gong F, Wu Y, Hou S, Xue L, Su Z and Zhang C: Poly-β-cyclodextrin supramolecular nanoassembly with a pH-sensitive switch removing lysosomal cholesterol crystals for antiatherosclerosis. Nano Lett. 21:9736–9745. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
You P, Mayier A, Zhou H, Yang A, Fan J, Ma S, Liu B and Jiang Y: Targeting and promoting atherosclerosis regression using hybrid membrane coated nanomaterials via alleviated inflammation and enhanced autophagy. Appl Mater Today. 26:1013862022. View Article : Google Scholar | |
|
Li C, Dou Y, Chen Y, Qi Y, Li L, Han S, Jin T, Guo J, Chen J and Zhang J: Site-specific microRNA-33 antagonism by pH-responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity. Adv Funct Mater. 30:20021312020. View Article : Google Scholar | |
|
He H, Wang J, Yannie PJ, Korzun WJ, Yang H and Ghosh S: Nanoparticle-based 'two-pronged' approach to regress atherosclerosis by simultaneous modulation of cholesterol influx and efflux. Biomaterials. 260:1203332020. View Article : Google Scholar | |
|
Wu Z, Zhou M, Tang X, Zeng J, Li Y, Sun Y, Huang J, Chen L, Wan M and Mao C: Carrier-free trehalose-based nanomotors targeting macrophages in inflammatory plaque for treatment of atherosclerosis. ACS Nano. 16:3808–3820. 2022. View Article : Google Scholar : PubMed/NCBI |
